LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 2 of total 2

Search options

  1. Article ; Online: Immunophenotypic markers for the evaluation of minimal/measurable residual disease in acute megakaryoblastic leukemia.

    Pinto, Carina Maria / Bertolucci, Camila Marques / Severino, Alef Rafael / Dos Santos Tosi, Juliana Fernanda / Ikoma-Colturato, Maura R V

    Hematology, transfusion and cell therapy

    2023  

    Abstract: Acute megakaryoblastic leukemia is characterized by heterogeneous biology and clinical behavior. Immunophenotypic characteristics include the expression of megakaryocytic differentiation markers (e.g. CD41, CD42a, CD42b, CD61) associated with immaturity ... ...

    Abstract Acute megakaryoblastic leukemia is characterized by heterogeneous biology and clinical behavior. Immunophenotypic characteristics include the expression of megakaryocytic differentiation markers (e.g. CD41, CD42a, CD42b, CD61) associated with immaturity markers (CD34, CD117, HLA-DR) and myeloid markers (e.g. CD13, CD33) and even with lymphoid cross-lineage markers (e.g. CD7, CD56). Although the diagnostic immunophenotype has already been well described, given the rarity of the disease, its immunophenotypic heterogeneity and post-therapeutic instability, there is no consensus on the combination of monoclonal markers to detect minimal/measurable residual disease (MRD). Currently, MRD is an important tool for assessing treatment efficacy and prognostic risk. In this study, we evaluated the immunophenotypic profile of MRD in a retrospective cohort of patients diagnosed with acute megakaryoblastic leukemia, to identify which markers, positive or negative, were more stable after treatment and which could be useful for MRD evaluation. The expression profile of each marker was evaluated in sequential MRD samples. In conclusion, the markers evaluated in this study can be combined in an MRD immunophenotypic panel to investigate for megakaryoblastic leukemia. Although this study is retrospective and some data are missing, the information obtained may contribute to prospective studies to validate more specific strategies in the detection of MRD in acute megakaryoblastic leukemia.
    Language English
    Publishing date 2023-11-17
    Publishing country Brazil
    Document type Journal Article
    ISSN 2531-1387
    ISSN (online) 2531-1387
    DOI 10.1016/j.htct.2023.09.2364
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Clinical validation of a 10-color flow cytometry panel to detect measurable residual disease in acute myeloid leukemia.

    Ikoma-Colturato, Maura R V / Severino, Alef Rafael / Dos Santos Tosi, Juliana Fernanda / Bertolucci, Camila Marques / Cuoco, Yeda Midori Nakamura / de Mattos, Ederson Roberto / Colturato, Iago / Silva, Fernanda Barbieri Rodrigues / de Souza, Mair Pedro / Simione, Anderson João / Colturato, Vergilio Antonio Rensi

    Leukemia research

    2024  Volume 140, Page(s) 107482

    MeSH term(s) Humans ; Neoplasm, Residual/diagnosis ; Flow Cytometry/methods ; Leukemia, Myeloid, Acute/diagnosis ; Leukemia, Myeloid, Acute/pathology ; Leukemia, Myeloid, Acute/therapy ; Middle Aged ; Female ; Male ; Aged ; Adult
    Language English
    Publishing date 2024-03-13
    Publishing country England
    Document type Letter ; Validation Study ; Research Support, Non-U.S. Gov't
    ZDB-ID 752396-8
    ISSN 1873-5835 ; 0145-2126
    ISSN (online) 1873-5835
    ISSN 0145-2126
    DOI 10.1016/j.leukres.2024.107482
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top